Item Type | Name |
Concept
|
Lymphoma, T-Cell
|
Concept
|
Lymphoma, B-Cell
|
Concept
|
Lymphoma, Mantle-Cell
|
Concept
|
Lymphoma, Large-Cell, Anaplastic
|
Concept
|
Lymphoma, B-Cell, Marginal Zone
|
Academic Article
|
Gastric MALT lymphoma treated with primary radiotherapy in the setting of autoimmune disease.
|
Academic Article
|
Radiation therapy is an effective modality in the treatment of mantle cell lymphoma, even in heavily pretreated patients.
|
Academic Article
|
Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
|
Academic Article
|
Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy.
|
Academic Article
|
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
|
Academic Article
|
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
|
Academic Article
|
Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy
|
Academic Article
|
Radiation Therapy for Diffuse Large B-Cell Lymphoma: Indications, Outcomes, and Controversies.
|
Academic Article
|
Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma.
|
Academic Article
|
ATM mutation and radiosensitivity: An opportunity in the therapy of mantle cell lymphoma.
|
Academic Article
|
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
|
Academic Article
|
Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma.
|
Academic Article
|
Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma.
|
Academic Article
|
Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions.
|
Academic Article
|
Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure.
|
Academic Article
|
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
|
Academic Article
|
Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.
|
Academic Article
|
Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma.
|
Academic Article
|
Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL.
|
Academic Article
|
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy.
|
Academic Article
|
Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy.
|
Academic Article
|
Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue.
|
Academic Article
|
Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
|
Academic Article
|
Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma.
|
Academic Article
|
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
|
Academic Article
|
Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma.
|
Academic Article
|
Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function.
|
Academic Article
|
An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement.
|
Academic Article
|
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma.
|
Academic Article
|
Breast Implant-associated Anaplastic Large Cell Lymphoma: A Prospective Series of 52 Patients.
|
Academic Article
|
Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement.
|
Academic Article
|
Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma.
|
Academic Article
|
The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy.
|
Academic Article
|
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma.
|
Academic Article
|
Primary Mediastinal B Cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium Society Appropriate Use Criteria.
|
Academic Article
|
Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy.
|
Academic Article
|
Salvage radiotherapy for primary refractory and relapsed diffuse large B-Cell lymphoma.
|
Academic Article
|
Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma.
|
Academic Article
|
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.
|
Academic Article
|
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant.
|
Academic Article
|
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.
|